Reproductive rights groups in the US are reacting to the recent Supreme Court decision regarding the challenge to the accessibility of mifepristone. The Center for Reproductive Rights expressed a mix of relief and anger over the ruling. The organization's president and CEO emphasized that while she was pleased with the decision, she believed the case should not have reached the Supreme Court.
The American Civil Liberties Union Reproductive Freedom Project also weighed in on the matter, cautioning that despite the apparent victory for reproductive rights, challenges to abortion rights in the US are likely to persist. The organization's director highlighted the ongoing threats posed by certain politicians.
On the other hand, Danco, the manufacturer of mifepristone, welcomed the Supreme Court's decision, stating that it ensures continued access to a drug with a long history of safe and effective use. The manufacturer reaffirmed its dedication to facilitating safe access to abortion services throughout the country.
